The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

The CDDF is delighted to announce that the summary report, Involving and Engaging People with Cancer in Oncology Drug Development, has been published today. This report is prepared by Professor Mark Lawler (Queen’s University Belfast & Board of the CDDF) and captures the key findings from the CDDF’s ‘Patient Access and Involvement in Oncology Drug Development’ multi-stakeholder workshop, which took place on the 19th – 20th September 2022 in Amsterdam, The Netherlands.

Read the summary and a series of 11 recommendations that represent the key output from the CDDF Workshop here:

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70